跳至主要内容
临床试验/ISRCTN64791295
ISRCTN64791295已完成不适用

A phase III, single-blind, single-centre trial to assess efficacy and tolerability of genital mucosa after use of product INC056 in post-menopausal women

Incrementha PD&I (Brazil)0 个研究点目标入组 65 人开始时间: 2008年8月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Healthy female volunteers aged between 40 and 65 years
  • 2. Post-menopausal women
  • 3. Vaginal pH of 5.0 or higher
  • 4. Written informed consent

排除标准

  • 1. Pregnancy or lactation
  • 2. Skin disease at site of administration
  • 3. Diabetes mellitus
  • 4. Immunological insufficiency
  • 5. Use of systemic corticoid, antibiotics or steroids
  • 6. Use of immunosuppressive drugs
  • 7. Skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis
  • 8. Antifungal therapy within the last month at screening
  • 9. History of infection at the site of drug administration
  • 10. History of allergies to components of product
  • 11. Other diseases or medications that could interfere with the research result or endanger the volunteer

研究者

发起方
Incrementha PD&I (Brazil)

相似试验

进行中(未招募)
不适用
HPV vaccine for the treatment and prevention of recurrent laryngeal papillomatosis, which is a bening tumor in the upper airways caused by HPVRecurrant respiratory papillomatosis
EUCTR2013-003049-41-HUational Institute of Child Health
进行中(未招募)
1 期
Open-label trial to check the safety and tolerability of RTX-GRT7039injections for pain associated with osteoarthritis of the knee.Moderate to severe pain associated with Osteoarthritis of the kneeMedDRA version: 21.1Level: LLTClassification code 10023476Term: Knee osteoarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2021-005046-15-PLGrünenthal GmbH930
进行中(未招募)
1 期
Open-label trial to check the safety and tolerability of RTX-GRT7039injections for pain associated with osteoarthritis of the knee.
EUCTR2021-005046-15-BGGrünenthal GmbH715
招募中
3 期
Open-label trial to check the safety and tolerability of RTX-GRT7039 injections for pain associated with osteoarthritis of the knee.
JPRN-jRCT2031230069ange Bernd, MD, MSc, Medical Lead11
进行中(未招募)
不适用
Booster vaccination with pneumococcal vaccine GSK1024850A or Prevenar™ co-administered with Hiberix™ in children primed with the same vaccines.Healthy volunteers (Booster vaccination at 12-18 months of age against Streptococcus pneumoniae and Haemophilus influenzae type b in healthy children primed with the same study vaccines in study 10PN-PD-DIT-036 (110808))MedDRA version: 18.0Level: LLTClassification code 10042197Term: Streptococcus pneumoniae septicaemiaSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10042195Term: Streptococcus pneumoniae pneumoniaSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10054642Term: Streptococcus pneumoniae septicemiaSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10035648Term: Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]System Organ Class: 100000004862
EUCTR2015-001506-34-Outside-EU/EEAGlaxoSmithKline Biologicals448